THE GLYCOSYLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN (GP41) IS IMPORTANT FOR THE EFFICIENT INTRACELLULAR-TRANSPORT OF THE ENVELOPE PRECURSOR GP160
E. Fenouillet et Im. Jones, THE GLYCOSYLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN (GP41) IS IMPORTANT FOR THE EFFICIENT INTRACELLULAR-TRANSPORT OF THE ENVELOPE PRECURSOR GP160, Journal of General Virology, 76, 1995, pp. 1509-1514
The role of the glycans of the human immunodeficiency virus type 1 tra
nsmembrane glycoprotein (gp41) in the intracellular events of Env prec
ursor (gp160) biosynthesis has been examined by the use of a mutant gp
160 in which the cluster of conserved glycosylation sites within the g
p41 domain (Asn-621, -630 and -642) has been mutated. Expression of th
e wild-type and mutant forms of gp160 in BHK-21 cells using recombinan
t vaccinia viruses has shown that the kinetics of the events occurring
in the endoplasmic reticulum (ER) were normal: both Env proteins had
similar kinetics of disulphide bond formation, as determined by the ac
quisition of CD4-binding capability, and both had similar kinetics of
oligomer formation. However, in contrast to the parental molecule, mut
ated gp160 displayed relatively slow transport from the cis to the med
ial Golgi where it was retained in the oligomeric state. Transport to
the trans Golgi was impaired, as determined by the sensitivity of gp16
0 to glycosidases. Cleavage of mutated gp160 at the gp120/gp41 junctio
n was substantially reduced but this was apparently not due to the inv
olvement of the gp41 glycosylation in the cleavage reaction by furin i
nasmuch as, in the baculovirus system, mutated gp160 could be cleaved
when recombinant furin was co-expressed. The reduced cleavage in mamma
lian cells may thus reflect the impaired routing of mutated Env to the
compartment where cleavage occurs. The glycan component of gp41 is, t
herefore, important for the efficient intracellular transport and proc
essing of gp160. gp160 lacking gp41 carbohydrates is an additional exa
mple, among few others, of a protein lacking glycans that is arrested
in the Golgi rather than the ER following its biosynthesis.